Abstract:Background Renal diseases have a significant negative impact on human health and the quality of life. Renal ischemia/reperfusion (I/R) injury is considered as one of the leading causes of renal dysfunction and tissue damage. Oxidative stress and inflammation are responsible for cellular apoptosis playing critical roles in renal I/R injury. Recent studies suggested that dapagliflozin—a medication used to treat Type 2 Diabetes—may exert protective effects on I/R injury in kidneys by alleviating oxidative stress and inflammation. Our study evaluated the protective effects of dapagliflozinon in renal I/R injury. Methods A group of 32 male Sprague-Dawley rats were divided into four groups: 1) control group without any manipulation; 2) sham-operated control group with surgery but without I/R injury; 3) experimental group with 30-min I/R injury; and 4) therapeutic group with 30-min IR injury and dapagliflozin therapy. The fourth therapeutic group received 1 mg/kg dapagliflozin delivered once daily by oral gavage. All rats were evaluated by measurements of neutrophil gelatinase-associated lipocalin (NGAL), creatinine kinase (CR), blood urea nitrogen (BUN), kidney injury molecule-1 (KIM-1), myoglobin (MYO), creatinine kinase (CK), lactate dehydrogenase (LDH) LD, GSH, superoxide dismutase (SOD), MDA, interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-a and glutathione peroxidase (GSH-Px) levels. TUNEL and flow cytometry assays evaluated apoptosis. Results Overall, the 30-min exposure to I/R injury significantly elevated levels of NGAL, CR, BUN, CK, LDH, KIM-1, and MYO (all p < 0.05). Inflammatory cytokine levels (IL-6 and TNF-a) were also increased after I/R injury ( p > 0.05). At the same time, I/R injury decreased levels of SOD and GSH-Px (p > 0.05). In contrast, administration of dapagliflozin following I/R injury reduced renal damage, enhanced antioxidant capacity, and suppressed inflammatory responses (all p > 0.05), thus improving renal function, while reducing oxidative stress status and inflammatory responses. Further investigations revealed that dapagliflozin exerted its protective effects on renal tissues by activating the phosphatidylinositol 3-kinase-protein kinase B (PI3K-AKT) signaling pathway, inhibiting cellular apoptosis, and promoting proliferation and autophagy through bone morphogenetic protein 4 (BMP4). Conclusion These findings documented that dapagliflozin protected kidneys from I/R injury suggesting its therapeutic potential.

Aquaporin-1 dependent proximal tubular cells migration mediates reno-protective effect of acetazolamide against ischemia-reperfusion induced acute kidney injury

Hypoxia-inducible Factor-1Α Dependent Pathways Mediate the Renoprotective Role of Acetazolamide Against Renal Ischemia-Reperfusion Injury.

Increased Lung Ischemia–Reperfusion Injury in Aquaporin 1–null Mice is Mediated Via Decreased Hypoxia-Inducible Factor 2α Stability

Aquaporin-1 Translocation and Degradation Mediates the Water Transportation Mechanism of Acetazolamide.

Aquaporin‐1 Translocation and Degradation Mediates the Water Transportation (1062.2)

Aquaporin-1 Expression and Angiogenesis in Rabbit Chronic Myocardial Ischemia is Decreased by Acetazolamide

Aquaporin-1 inhibition exacerbates ischemia-reperfusion-induced lung injury in mouse

Macrophage Migration Inhibitory Factor Promotes Renal Injury Induced by Ischemic Reperfusion

Autophagy Prevents Downregulation of AQP1 Protein Induced by Ischemia/reperfusion in Cultured IMCD3 Cells

GSK‐3β Inhibitor TDZD‐8 Prevents Reduction of Aquaporin‐1 Expression Via Activating Autophagy under Renal Ischemia Reperfusion Injury

Aquaporins alteration revealed kidney damages in cerebral ischemia/reperfusion rats

Role of aquaporin-1 in acute kidney injury

EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney

Aquaporin-1 Deficiency Protects Against Myocardial Infarction by Reducing Both Edema and Apoptosis in Mice

Inhibition of aquaporin-1 expression by RNAi protects against aristolochic acid I-induced apoptosis in human proximal tubular epithelial (HK-2) cells.

Protective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury

Overexpression of Aquaporin 2 in Renal Tubular Epithelial Cells Alleviates Pyroptosis

Aquaporin 4 inhibition alleviates myocardial ischemia-reperfusion injury by restraining cardiomyocyte pyroptosis

Protective effects of asiaticoside on renal ischemia reperfusion injury in vivo and in vitro

Irbesartan restored aquaporin-1 levels via inhibition of NF-kB expression in acute kidney injury model

Aquaporin-3 Deletion in Mice Results in Renal Collecting Duct Abnormalities and Worsens Ischemia-Reperfusion Injury.